Status:
COMPLETED
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
California HealthCare Foundation
Conditions:
Necrotizing Pancreatitis
Eligibility:
All Genders
18+ years
Brief Summary
Necrotizing pancreatitis is a severe form of inflammation of the pancreas with subsequent destruction of the pancreas (necrosis). Often, this condition manifests in patients as an overwhelming systemi...
Detailed Description
In this study, patients with severe necrotizing pancreatitis will be followed prospectively throughout their hospital course (anticipated duration of hospitalization ranging between 4-8 weeks). If pat...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years
- Severe necrotizing pancreatitis as evidenced by clinical examination, biochemical analysis, and/or imaging studies demonstrating pancreatitis and pancreatic necrosis
Exclusion
- Age less than 18 years old
- Participation in another device or drug study
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01815489
Start Date
July 1 2011
End Date
May 1 2014
Last Update
April 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carolinas Medical Center
Charlotte, North Carolina, United States, 28204